Cytosolic Ovarian Carcinoma Antigen 1 (COVA1)

[Edit]

APK1; tNOX; ENOX2; Ecto-NOX Disulfide-Thiol Exchanger 2; Tumor-associated hydroquinone oxidase; Hydroquinone [NADH] oxidase; Protein disulfide-thiol oxidoreductase

Cytosolic Ovarian Carcinoma Antigen 1 (COVA1)

is a growth-related cell surface protein. It was identifed because it reacts with the monoclonal antibody KI in cells, such as the ovarian carcinoma line OVCAR-3, also expressing the CAKI surface glycoprotein. The encoded protein has two enzymatic activities: catalysis of hydroquinone or NADH oxidation, and protein disulfide interchange. The two activities alternate with a period length of about 24 minutes. The encoded protein also displays prion-like properties. Two transcript variants encoding different isoforms have been found for this gene.The COVA1 protein contains 3 potential N-linked glycosylation sites and multiple potential phosphorylation sites. Northern blot analysis revealed expression of a major 3.8-kb transcript predominantly in heart, placenta, and skeletal muscle but also in lung, liver, kidney, and pancreas.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC458Hu01 Recombinant Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAC458Hu01 Polyclonal Antibody to Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC458Mu01 Recombinant Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAC458Mu01 Polyclonal Antibody to Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) ELISA Kit Customized Service Offer
  1. "Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface."Biochemistry 41:3732-3741(2002) [PubMed] [Europe PMC] [Abstract]
  2. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  3. "The DNA sequence of the human X chromosome." Nature 434:325-337(2005) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface."Arch. Biochem. Biophys. 391:149-159(2001) [PubMed] [Europe PMC] [Abstract]
  6. "Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line."Int. J. Cancer 57:90-97(1994) [PubMed] [Europe PMC] [Abstract]
  7. "Inhibition of plasma membrane NADH oxidase activity and growth of HeLa cells by natural and synthetic retinoids."Mol. Cell. Biochem. 166:101-109(1997) [PubMed] [Europe PMC] [Abstract]
  8. "The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity."J. Bioenerg. Biomembr. 30:477-487(1998) [PubMed] [Europe PMC] [Abstract]
  9. "The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity."Biochim. Biophys. Acta 1412:66-77(1999) [PubMed] [Europe PMC] [Abstract]
  10. "Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion."Biochemistry 40:7351-7354(2001) [PubMed] [Europe PMC] [Abstract]
  11. "Surface NADH oxidase of HeLa cells lacks intrinsic membrane binding motifs."Arch. Biochem. Biophys. 392:251-256(2001) [PubMed] [Europe PMC] [Abstract]
  12. "Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients."Cancer Immunol. Immunother. 51:121-129(2002) [PubMed] [Europe PMC] [Abstract]
  13. "Biochemical basis for the biological clock."Biochemistry 41:11941-11945(2002) [PubMed] [Europe PMC] [Abstract]
  14. "Diagnostic exome sequencing in persons with severe intellectual disability."N. Engl. J. Med. 367:1921-1929(2012) [PubMed] [Europe PMC] [Abstract]